(R)-2-Amino-2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)propan-1-ol

ID: ALA4546247

Chembl Id: CHEMBL4546247

PubChem CID: 155553341

Max Phase: Preclinical

Molecular Formula: C14H21N3O

Molecular Weight: 247.34

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1ccc2[nH]c([C@@](C)(N)CO)nc2c1

Standard InChI:  InChI=1S/C14H21N3O/c1-13(2,3)9-5-6-10-11(7-9)17-12(16-10)14(4,15)8-18/h5-7,18H,8,15H2,1-4H3,(H,16,17)/t14-/m0/s1

Standard InChI Key:  YWRJRDVPJPUXJJ-AWEZNQCLSA-N

Alternative Forms

  1. Parent:

    ALA4546247

    ---

Associated Targets(Human)

SCN10A Tclin Sodium channel protein type X alpha subunit (396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 247.34Molecular Weight (Monoisotopic): 247.1685AlogP: 2.03#Rotatable Bonds: 2
Polar Surface Area: 74.93Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.48CX Basic pKa: 7.86CX LogP: 1.96CX LogD: 1.37
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -0.78

References

1. Brown AD, Bagal SK, Blackwell P, Blakemore DC, Brown B, Bungay PJ, Corless M, Crawforth J, Fengas D, Fenwick DR, Gray V, Kemp M, Klute W, Malet Sanz L, Miller D, Murata Y, Payne CE, Skerratt S, Stevens EB, Warmus JS..  (2019)  The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain.,  27  (1): [PMID:30538065] [10.1016/j.bmc.2018.12.002]

Source